B7-H4 Offers Potential Treatment Target in a Variety of Solid Tumors

The transmembrane protein B7-H4 has emerged as an interesting therapeutic target in multiple solid tumors, with investigators mostly focusing on the development of antibody-drug conjugates aimed at the pathway.

Related Keywords

United States ,Illinois ,Orlando ,Florida ,Japan ,South Korea ,Madrid ,Spain ,Australia ,Chicago ,American ,Josephr Podojil , ,American Association For Cancer Research ,American Society Of Clinical Oncology Annual Meeting ,European Society For Medical Oncology Congress ,Northwestern University Feinberg School Of Medicine ,Northwestern University Feinberg School ,Study Provides Proof ,Cancer Research ,Annual Meeting ,Medical Oncology Congress ,Clinical Trials Look ,Advance New ,Clinical Oncology Annual Meeting ,B7 H4 ,Phd ,